As of November 1st, 2023, Dr. Stephan Haitz will assume the role of President of the Novasep CDMO Business Unit and will become a member of the company's Executive Committee, succeeding Jean Bléhaut, who is departing the company after a distinguished career spanning over 25 years.
Dr. Haitz brings with him a wealth of experience, with a career in the pharmaceutical industry exceeding two decades. He has held various managerial positions within prominent global CDMOs, including Solvias, Lonza, and Cambrex. Dr. Haitz holds a PhD and a Master's degree in organic chemistry, along with a Bachelor of Science degree in economics. Most recently, he served as President Drug Substance CDMO Commercial at Cambrex.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!